MAGE-A3 Antigen-Specific Cancer Immunotherapeutic (ASCI) as adjuvant therapy in resected stage IB/II non-small cell lung cancer (NSCLC): from proof-of-concept to phase III trial (MAGRIT)

Lung Cancer ◽  
2009 ◽  
Vol 63 ◽  
pp. S10
Author(s):  
T. Eisen ◽  
J. Vansteenkiste ◽  
M. Zielinski ◽  
A. Linder ◽  
J. Dahabreh ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document